Roderik Kortlever

Roderik Kortlever is a cancer researcher affiliated with The Francis Crick Institute in London. His work spans institutions including the Netherlands Cancer Institute and the University of Cambridge, focusing on oncogenes, tumor suppression, and immune regulation in cancer progression.

• PhD in Cell Biology from the Netherlands Cancer Institute
• Postdoctoral research in the labs of René Bernards and Gerard Evan
• Current research at the Crick on Myc signaling, inflammation, and tissue regeneration in tumors

Research interests center on oncogene-tumor suppressor interactions, Myc-driven immune evasion, and mechanistic modeling of cancer heterogeneity. His studies bridge Cell Biology, Immunology, and Genomics, with implications for pancreatic, lung, and breast cancer therapies.

Scientific contributions include:

• Discovery of Myc-Ras collaboration in inflammation and immune suppression
• Elucidation of Myc’s role in pancreatic cancer phenotypes
• Development of models for tumor heterogeneity and therapeutic targeting

Scientific awards:

• Research Fellow (4 times)

Labs/teams: Genomics, Flow Cytometry, and Experimental Histopathology facilities at the Crick, contributing to international consortia like TRACERx.